Seagull Technologies Pty Ltd has delivered FDA approved drugs for the treatment of Macular Degeneration and inflammatory eye diseases without the need for injections. The unique technology is a cross-platform, non-invasive drug and biologic delivery system and device that utilizes a combination of polymer-gels, nanotechnology and ultrasound.Use in Agribusiness and Cosmeceuticals is expected.
| Website | http://www.seagulltechnologies.com.au |
| Revenue | $8.8 million |
| Employees | 2 (0 on RocketReach) |
| Address | 25 Bligh St Ste 24.02, Sydney, New South Wales 2000, AU |
| Phone | +61 421 669 367 |
| Industry | Manufacturing General, Manufacturing |
| Keywords | Fda Approved Drugs, Ophthalmic Drug Delivery, Eye Disease Treatment, Drug Delivery Technology, Ocular Drug Delivery, Ophthalmology Technology, Innovative Drug Delivery, Pharmaceutical Technology, Advanced Drug Delivery, Vision Care Technology, Pharmaceutical Research, Eye Medication, Medical Technology |
| Competitors | Horizon IT Solutions, IT Vision Pty Ltd, Synergy IT Group, Visionary IT, Redefine Pty Ltd, blendit australia, Datascape Pty Ltd, Future Digital (view competitors) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Seagull Technologies employee's phone or email?
Seagull Technologies Questions
The Seagull Technologies annual revenue was $8.8 million in 2026.
Seagull Technologies is based in Sydney, New South Wales.
The NAICS codes for Seagull Technologies are [3254, 32, 325, 32541].
The SIC codes for Seagull Technologies are [28, 283].
